56 related articles for article (PubMed ID: 2286386)
1. Amsacrine binds in a cooperative manner to deoxyribonucleic acid.
Ojha RP; Sanyal NK
Indian J Biochem Biophys; 1990 Aug; 27(4):219-21. PubMed ID: 2286386
[TBL] [Abstract][Full Text] [Related]
2. Cooperative binding of m-AMSA to nucleic acids.
Elmore RH; Wadkins RM; Graves DE
Nucleic Acids Res; 1988 Oct; 16(20):9707-19. PubMed ID: 3186443
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic action and cell cycle effects of ALGA, a peptidic derivative of the antileukemic drug amsacrine.
Collyn-d'Hooghe M; Bernier JL; Henichart JP
Cancer Biochem Biophys; 1987 Sep; 9(3):257-64. PubMed ID: 3435897
[TBL] [Abstract][Full Text] [Related]
4. Adriamycin and daunorubicin bind in a cooperative manner to deoxyribonucleic acid.
Graves DE; Krugh TR
Biochemistry; 1983 Aug; 22(16):3941-7. PubMed ID: 6615810
[TBL] [Abstract][Full Text] [Related]
5. Steric constraints for DNA binding and biological activity in the amsacrine series.
Denny WA; Twigden SJ; Baguley BC
Anticancer Drug Des; 1986 Apr; 1(2):125-32. PubMed ID: 3450288
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the antitumour drug 4'-(9-acridinylamino)-methanesulfon-m-anisidine.HCl (m-AMSA) with nucleic acids.
Hudecz F; Kajtár J; Szekerke M
Nucleic Acids Res; 1981 Dec; 9(24):6959-73. PubMed ID: 6174949
[TBL] [Abstract][Full Text] [Related]
7. Thermodynamics of the interactions of m-AMSA and o-AMSA with nucleic acids: influence of ionic strength and DNA base composition.
Wadkins RM; Graves DE
Nucleic Acids Res; 1989 Dec; 17(23):9933-46. PubMed ID: 2602146
[TBL] [Abstract][Full Text] [Related]
8. DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II.
Rowe TC; Chen GL; Hsiang YH; Liu LF
Cancer Res; 1986 Apr; 46(4 Pt 2):2021-6. PubMed ID: 3004716
[TBL] [Abstract][Full Text] [Related]
9. Toxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide in exponential- and plateau-phase Chinese hamster cell cultures.
Wilson WR; Giesbrecht JL; Hill RP; Whitmore GF
Cancer Res; 1981 Jul; 41(7):2809-16. PubMed ID: 6894713
[TBL] [Abstract][Full Text] [Related]
10. Interactions of anilinoacridines with nucleic acids: effects of substituent modifications on DNA-binding properties.
Wadkins RM; Graves DE
Biochemistry; 1991 Apr; 30(17):4277-83. PubMed ID: 2021620
[TBL] [Abstract][Full Text] [Related]
11. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
[TBL] [Abstract][Full Text] [Related]
12. Lethal activity and kinetic response of cultured human cells to 4'-(9-acridinylamino)methanesulfon-m-anisidine.
Drewinko B; Yang LY; Barlogie B
Cancer Res; 1982 Jan; 42(1):107-11. PubMed ID: 6895609
[TBL] [Abstract][Full Text] [Related]
13. DNA intercalating properties of tetrahydro-9-aminoacridines. Synthesis and 23Na NMR spin-lattice relaxation time measurements.
Dinesen J; Jacobsen JP; Hansen FP; Pedersen EB; Eggert H
J Med Chem; 1990 Jan; 33(1):93-7. PubMed ID: 2296037
[TBL] [Abstract][Full Text] [Related]
14. Interaction of DNA-threading peptide-amsacrine conjugates with DNA and chromatin.
Bourdouxhe-Housiaux C; Colson P; Houssier C; Bailly C
Anticancer Drug Des; 1996 Oct; 11(7):509-25. PubMed ID: 8921934
[TBL] [Abstract][Full Text] [Related]
15. Energetics and stereochemistry of DNA complexation with the antitumor AT specific intercalators tilorone and m-AMSA.
Chen KX; Gresh N; Pullman B
Nucleic Acids Res; 1988 Apr; 16(7):3061-73. PubMed ID: 3368315
[TBL] [Abstract][Full Text] [Related]
16. Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol.
Adlakha RC; Ashorn CL; Chan D; Zwelling LA
Cancer Res; 1989 Apr; 49(8):2052-8. PubMed ID: 2539251
[TBL] [Abstract][Full Text] [Related]
17. Interaction of the antitumor drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines with nucleic acids.
Wilson WR; Baguley BC; Wakelin LP; Waring MJ
Mol Pharmacol; 1981 Sep; 20(2):404-14. PubMed ID: 6170872
[No Abstract] [Full Text] [Related]
18. m-AMSA in refractory lymphoma. A phase II trial of the Eastern Cooperative Oncology Group.
Keller AM; Tsiatis AA; Neiman RS; Glick JH; Mann RB
Am J Clin Oncol; 1985 Oct; 8(5):449-52. PubMed ID: 3840644
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerase II-mediated DNA damage produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines in L1210 cells and isolated nuclei: relation to cytotoxicity.
Covey JM; Kohn KW; Kerrigan D; Tilchen EJ; Pommier Y
Cancer Res; 1988 Feb; 48(4):860-5. PubMed ID: 2827887
[TBL] [Abstract][Full Text] [Related]
20. The binding of the anthelmintic pyrvinium cation to deoxyribonucleic acid in vitro.
Dickie P; Morgan AR; Scraba DG; von Borstel RC
Mol Pharmacol; 1986 Apr; 29(4):427-35. PubMed ID: 3702861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
